About Calcitonin receptor
Calcitonin receptor (CALCR) is a protein
from Homo sapiens identified by UniProt accession
P30988, 474 residues long.
MolForge cross-references it against 0 known binders and
224 disease associations.
Target properties
| Protein name | Calcitonin receptor |
| UniProt accession | P30988 |
| Gene | CALCR |
| Organism | Homo sapiens |
| Length | 474 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (2)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (224)
Diseases linked to this target (Open Targets).
- type 2 diabetes mellitus · score 0.66
- type 1 diabetes mellitus · score 0.57
- postmenopausal osteoporosis · score 0.53
- body mass index · score 0.49
- diabetes mellitus · score 0.47
- bone fracture · score 0.46
- parathyroid disease · score 0.46
- pain · score 0.46
- lean body mass · score 0.42
- triglyceride measurement · score 0.39
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P30988-F1 | alphafold | PREDICTED | 78.69 | — |
Amino-acid sequence (474 residues)
MRFTFTSRCL ALFLLLNHPT PILPAFSNQT YPTIEPKPFL YVVGRKKMMD AQYKCYDRMQ QLPAYQGEGP YCNRTWDGWL CWDDTPAGVL SYQFCPDYFP DFDPSEKVTK YCDEKGVWFK HPENNRTWSN YTMCNAFTPE KLKNAYVLYY LAIVGHSLSI FTLVISLGIF VFFRSLGCQR VTLHKNMFLT YILNSMIIII HLVEVVPNGE LVRRDPVSCK ILHFFHQYMM ACNYFWMLCE GIYLHTLIVV AVFTEKQRLR WYYLLGWGFP LVPTTIHAIT RAVYFNDNCW LSVETHLLYI IHGPVMAALV VNFFFLLNIV RVLVTKMRET HEAESHMYLK AVKATMILVP LLGIQFVVFP WRPSNKMLGK IYDYVMHSLI HFQGFFVATI YCFCNNEVQT TVKRQWAQFK IQWNQRWGRR PSNRSARAAA AAAEAGDIPI YICHQELRNE PANNQGEESA EIIPLNIIEQ ESSA
Explore Calcitonin receptor with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets